Accueil > Actualité
Actualite financiere : Actualite bourse

Almirall: positive results in actinic keratosis

( - Spanish drugmaker Almirall and US partner Athenex said that they have attained positive top-line results in two studies for KX2-391 in actinic keratosis, a common skin condition that results in patches of thick, scaly or crusty skin.

Both Phase III studies achieved their primary endpoints, defined as 100% clearance of the lesions at day 57 within the face or scalp treatment areas.

Results show that 44% and 54% of patients achieved 100% actinic keratosis lesion clearance, the companies said.

Actinic keratosis is the most common pre-cancerous condition in dermatology. It affects 55 million Americans.

Copyright (c) 2019 All rights reserved.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.
Indices et cours différés d’au moins 15 mn | Cotations boursières fournies par ABC Bourse.